PHENOBARBITAL PHARMACOKINETICS AND BIOAVAILABILITY IN ADULTS

被引：62

作者：

NELSON, E

POWELL, JR

CONRAD, K

LIKES, K

BYERS, J

BAKER, S

PERRIER, D

机构：

[1] UNIV ARIZONA,COLL MED,DEPT INTERNAL MED,TUCSON,AZ 85721

[2] UNIV ARIZONA,COLL MED,DEPT CLIN PATHOL,TUCSON,AZ 85721

[3] UNIV N CAROLINA,SCH PHARM,DEPT PHARM PRACTICE,CHAPEL HILL,NC 27514

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 1982年 / 22卷 / 2-3期

关键词：

D O I：

10.1002/j.1552-4604.1982.tb02662.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：141 / 148

页数：8

共 16 条

[1]

ALVIN J, 1975, J PHARMACOL EXP THER, V192, P224

[2] PHENOBARBITAL METABOLISM IN ADULTS AND IN NEWBORN-INFANTS [J].

BOREUS, LO ;

JALLING, B ;

KALLBERG, N .

ACTA PAEDIATRICA SCANDINAVICA, 1978, 67 (02) :193-200

[3] STATISTICAL ESTIMATIONS IN PHARMACOKINETICS [J].

BOXENBAU.HG ;

RIEGELMA.S ;

ELASHOFF, RM .

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1974, 2 (02) :123-148

[4]

BUCTHAL F, 1968, ARCH NEUROL, V19, P567

[5]

BUTLER TC, 1954, J PHARMACOL EXP THER, V111, P425

[6] QUANTITATION OF PHENOBARBITAL AND ITS MAIN METABOLITES IN HUMAN URINE [J].

KALLBERG, N ;

AGURELL, S ;

ERICSSON, O ;

BUCHT, E ;

JALLING, B ;

BOREUS, LO .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 9 (2-3) :161-168

[7]

LOUS P, 1954, ACTA PHARMACOL TOX, V10, P147

[8]

MARTIN PR, 1979, CLIN PHARMACOL THER, V26, P256

[9]

METZLER CM, 1969, USER MANUAL NONLIN

[10] EFFECT OF ACTIVATED-CHARCOAL ON ABSORPTION AND ELIMINATION OF PHENOBARBITONE, CARBAMAZEPINE AND PHENYLBUTAZONE IN MAN [J].

NEUVONEN, PJ ;

ELONEN, E .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 17 (01) :51-57

← 1 2 →